Digital health coaching platform Liva Healthcare has secured funding from the EU Horizon 2020 programmes to help treat pregnant women at risk of Type 2 diabetes.
Liva Healthcare will be part of the Impact Diabetes Baby 2 Bump (IDB2B) research project, which aims to identify and help pregnant women and their babies both at highest risk of developing Type 2 diabetes.
Horizon 2020 is the European Union’s framework programme to boost research and innovation. Starting in 2014, with a dedicated budget of around €77bn, it is the biggest EU research programme.
‘After huge success in the UK working on the NHS Diabetes Prevention program this latest news brings Liva Healthcare to the forefront of cutting-edge research,’ said Kristoffer From, the co-founder and CEO of Liva Healthcare. ‘We are proud to contribute to such important research that looks to prevent maternal and child diabetes. Our team are looking forward to working with other experts across Ireland, Spain, UK, Australia and Denmark.’
Sharleen O’Reilly, lead on the IDB2B-project, said: ‘We are grateful for the funding we have received from the EU to begin working on this exciting project. Pregnant women have previously been a more difficult-to-treat group and we welcome more research to speed up advancements care for expectant mothers.’